Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure
Links shared publicly online about this topic.
- 1,510total visits
Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure
Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure
View full resource at novartis.com
Tags: Heart, Heart Disease, Heart Failure, Novartis
Most Recently Shared on January 4, 2010 at 3:15 pm By:
More Novartis acquisition - Novartis to acquire Corthera Inc., http://ow.ly/SAEn
Also Shared By:
Advertisement
Lisa Jarvis
@lisamjarvis
Novartis pays $120mm to acquire Cortheras, gains Relaxin, heart failure drug in PhaseIII trials: http://bit.ly/6qIMWX
1 year ago...